Home Health Business Quarterly
Blood thinning agent approved
For the first time, the U.S. Food & Drug Administration has approved a blood-thinning agent for the prevention of blood clots know as deep-vein thrombosis.
Lovenox, a low-molecular weight heparin from Aventis Pharmaceuticals in Parsippany, NJ, was approved for patients with restricted mobility at risk for thromboembolic complications from illnesses such as heart failure, respiratory failure, severe infection, back pain, vertebral compression, and arthritic episodes.
Article Limit Reached
You have reached your article limit for the month. Subscribe now to access this article plus other member-only content.
- Award-winning Medical Content
- Latest Advances & Development in Medicine
- Unbiased Content